Pharmaceutical Market Expansion in Europe

EuroDev helps pharmaceutical, laboratory, and in-vitro diagnostics companies enter, grow, and scale in Europe through market development, partner identification, local sales execution, and operational setup. With an execution-first approach, we act as your on-the-ground European team, connecting your medical products and services to trusted partners and reducing risk as you expand into new markets.

Discuss your European Expansion Strategy

What we do

How EuroDev supports pharmaceutical brands entering Europe

Commercial execution, operational setup, and the structured process that ties them together - so your team at HQ stays focused while we build your European presence.

Commercial & Growth Execution
- Local commercial representation under your brand
- Lead generation and sales pipeline development
- Channel, distributor, and partner identification
- Market validation and Go‑to‑Market planning
Our 5‑Step Expansion Framework

01 Market assessment - demand, competition, regulatory fit (EMA, MDR/IVDR, national requirements)
02 Go‑to‑market strategy - positioning, channels, buyer groups
03 Local representation or hiring - outsourced sales team or compliant hiring
04 Sales pipeline development - outreach, meetings, and opportunity creation
05 Ongoing operational support - activity tracking, sales operations alignment, and reporting to HQ
Operational & HR Support
- Local hiring via our PEO/EOR model
- Legal entity setup and ongoing administrative coordination
- Operational alignment between your European presence and HQ

Our expertise

Built for complex pharmaceutical buying environments

We've supported pharmaceutical and diagnostics manufacturers selling into some of Europe's most demanding procurement processes: hospital tenders, laboratory networks, and distributor qualification. We know the buying cycles, the gatekeepers, and the compliance timelines that get pharma companies to pipeline faster.

3-5 months

Typical time to first qualified pipeline

EU - wide

All European markets covered by multilingual business development teams

Industry insights

Latest from our European market analysts

How to Know When Your Company Is Ready to Expand into Europe →

Emerging Trends in the European Pharmaceutical Industry →

See How We'd Approach Your European Expansion

The opportunity

Why expand your pharmaceutical business into Europe?

Europe is one of the world's largest and most research-driven pharmaceutical markets.
It is projected to reach USD 432.12 billion by 2028, growing at a CAGR of 5.4%,
supported by an ageing population and the steady approval and launch of novel products.

Home to many of the world's largest pharma companies, leading research and design institutes, and hospitals that foster clinical innovation for rare and life-threatening diseases

Hospitals remain the backbone of European healthcare, creating concentrated, high-value buying centres

Growing demand for chronic care, particularly oncology, across the UK, Italy, Spain, Greece, Sweden, the Netherlands, and Norway

Strengthening healthcare systems in France, Germany, Finland, Portugal, Switzerland, and Belgium

A structured regulatory framework guiding quality, efficacy, safety, and sustainability standards

Where Europe sits in the global pharma market

Sources: IQVIA

United States

53%

Europe

24%

Asia-Pacific

11%

Rest of the world

12%

The decision

Direct expansion vs. partner-led market entry

Tapping into the European pharmaceutical market isn't straightforward. Fragmented national systems, hospital tenders, and strict regulation mean most companies spend more than they planned.

Challenges of Direct Expansion

× Long sales cycles without local presence

× Difficulty accessing OEMs, integrators, and industrial buyers

× Complex employment, tax, and compliance requirements

× High upfront investment, limited market visibility

× Slow entry due to unfamiliar procurement processes

Advantages of EuroDev’s Partner-Led Approach

✓ In front of the right OEM buyers in your first quarter, not your first year

✓ Local sales presence under your brand — no entity needed

✓ Reduced risk and predictable costs, no compliance gaps

✓ Full operational and HR support, HQ stays focused

✓ Established operational networks accelerate go-to-market

Stories from our Partners

Trends and developments to watch in 2023

During the COVID-19 period, the pharmaceutical industry was characterized by fast-paced research that continuously put the entire healthcare sector on a rise.
Read more
Case Study: In-vitro Diagnostics

Read more on how we worked with the manufacturer of drug testing products and helped them to build a network of solid and find reliable distributors.
Read our case study
Selecting the Right Sales Outsourcing Partner

For many pharmaceutical manufacturers, selecting the right sales outsourcing partner is now a strategic need. Planning for this aspect often takes one to two years.
Read more